It’s unfortunate that the drug companies decided to end their trials early, by giving active covid vaccine to the members of the placebo group after just a few months. It means that there is no long term follow-up of the …
Covid: How long does vaccine based immunity last?
It’s unfortunate that the drug companies decided to end their trials early, by giving active covid vaccine to the members of the placebo group after just a few months. It means that there is no long term follow-up of the …
Natural infection vs vaccination: Which gives more protection?
Nearly 40% of new COVID patients were vaccinated – compared to just 1% who had been infected previously.
Source: Natural infection vs vaccination: Which gives more protection?…
Does it make sense to vaccinate those who have had covid?
One of the strangest things about the last few months on planet Earth has been the relentless drive to vaccinate everyone, regardless of what their individual risk from the virus is, and whether or not they’ve already had the disease. …
“Proof that puts an end to the Sars-CoV-2 Narrative” | Professor Sucharit Bhakdi
Source: “Proof that puts an end to the Sars-CoV-2 Narrative” | Professor Sucharit Bhakdi…
Even Mild COVID-19 Cases Can Deliver Antibody Protection For Life, Study Finds
Even a mild case of COVID-19 can create antibodies that could give you lifetime protection from the virus, according to a new study.
“Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping …
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans | Nature
Abstract
Long-lived bone marrow plasma cells (BMPCs) are a persistent and essential source of protective antibodies1–7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent individuals have a significantly lower risk of reinfection8–10. Nonetheless, it has been reported that anti-SARS-CoV-2 serum …
SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition
The SARS-CoV-2 pandemic calls for the rapid development of diagnostic, preventive, and therapeutic approaches. CD4+ and CD8+ T cell-mediated immunity is central for control of and protection from viral infections[1-3]. A prerequisite to characterize T-cell immunity, but also for the …
Corona, the simple truth in under 6 minutes
This short video is a great summary of all our work we have done when it comes to so called Covid-19.
Corona, the simple truth in under 6 minutes…
Immunity to COVID-19 is probably higher than tests have shown
Source: Immunity to COVID-19 is probably higher than tests have shown
New research from Karolinska Institutet and Karolinska University Hospital shows that many people with mild or asymptomatic COVID-19 demonstrate so-called T-cell-mediated immunity to the new coronavirus, even if they …
Over half of people tested in Italy’s Bergamo have COVID-19 antibodies
More than half the residents tested in Italy’s northern province of Bergamo have COVID-19 antibodies, health authorities said on Monday, citing a sample survey.
Source: Over half of people tested in Italy’s Bergamo have COVID-19 antibodies…
